Analytics - Page 5 of 19

Most age-related diseases — from cancer to neurodegeneration — connect back to one core problem: over time, cells get worse at storing their DNA safely and using it correctly. In the “Hallmarks of Aging” framework(which we discussed here), researchers highlight three aging processes that sit right on top of our genetic material: DNA damage, telomere shortening, and epigenetic drift, when the settings that control gene activity get noisy.

A new Nature Communications study suggests that insulin resistance tracks with higher risk for 12 cancer types. An international research team applied an unusual approach — instead of measuring insulin resistance directly, they developed an algorithmic proxy, opening the door to population-scale risk analyses. Here’s why that matters.

In recent years, GLP-1–based weight-loss drugs have decisively moved beyond a narrow medical topic and become a mainstream subject of discussion in the US, Europe, and Canada. Explosive demand growth, intensifying competition, and expectations of change driven by patent timelines have turned the search for Ozempic alternatives into a practical question: what should you choose if Ozempic is hard to obtain, too expensive, or poorly tolerated?